Transcriptomic-Based Identification of the Immuno-Oncogenic Signature of Cholangiocarcinoma for HLC-018 Multi-Target Therapy Exploration

Cholangiocarcinomas (CHOLs), hepatobiliary malignancies, are characterized by high genetic heterogeneity, a rich tumor microenvironment, therapeutic resistance, difficulty diagnosing, and poor prognoses. Current knowledge of genetic alterations and known molecular markers for CHOL is insufficient, n...

Descripción completa

Detalles Bibliográficos
Autores principales: Lawal, Bashir, Kuo, Yu-Cheng, Tang, Sung-Ling, Liu, Feng-Cheng, Wu, Alexander T. H., Lin, Hung-Yun, Huang, Hsu-Shan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616156/
https://www.ncbi.nlm.nih.gov/pubmed/34831096
http://dx.doi.org/10.3390/cells10112873

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616156/
https://www.ncbi.nlm.nih.gov/pubmed/34831096
http://dx.doi.org/10.3390/cells10112873

Ejemplares similares